EP3157943A4 - Methods of treating or ameliorating migraine - Google Patents

Methods of treating or ameliorating migraine Download PDF

Info

Publication number
EP3157943A4
EP3157943A4 EP15811633.5A EP15811633A EP3157943A4 EP 3157943 A4 EP3157943 A4 EP 3157943A4 EP 15811633 A EP15811633 A EP 15811633A EP 3157943 A4 EP3157943 A4 EP 3157943A4
Authority
EP
European Patent Office
Prior art keywords
treating
methods
migraine
ameliorating
ameliorating migraine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15811633.5A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3157943A1 (en
Inventor
Joseph R. Moskal
Patric STANTON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwestern University
Naurex Inc
Original Assignee
Northwestern University
Naurex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwestern University, Naurex Inc filed Critical Northwestern University
Publication of EP3157943A1 publication Critical patent/EP3157943A1/en
Publication of EP3157943A4 publication Critical patent/EP3157943A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP15811633.5A 2014-06-23 2015-06-23 Methods of treating or ameliorating migraine Withdrawn EP3157943A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462015727P 2014-06-23 2014-06-23
US201562109386P 2015-01-29 2015-01-29
PCT/US2015/037177 WO2015200322A1 (en) 2014-06-23 2015-06-23 Methods of treating or ameliorating migraine

Publications (2)

Publication Number Publication Date
EP3157943A1 EP3157943A1 (en) 2017-04-26
EP3157943A4 true EP3157943A4 (en) 2018-01-24

Family

ID=54938737

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15811633.5A Withdrawn EP3157943A4 (en) 2014-06-23 2015-06-23 Methods of treating or ameliorating migraine

Country Status (10)

Country Link
EP (1) EP3157943A4 (ja)
JP (2) JP6688748B2 (ja)
KR (1) KR20170018072A (ja)
CN (1) CN106661085A (ja)
AU (1) AU2015280108B2 (ja)
BR (1) BR112016030375A8 (ja)
CA (1) CA2953170A1 (ja)
MX (1) MX2016017388A (ja)
RU (1) RU2721401C2 (ja)
WO (1) WO2015200322A1 (ja)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086828A1 (en) * 2000-08-25 2002-07-04 Harris Robert H. Uses for amino acid anticonvulsants
WO2011003064A2 (en) * 2009-07-02 2011-01-06 Naurex, Inc. Methods of treating neuropathic pain
WO2011044089A2 (en) * 2009-10-05 2011-04-14 Joseph Moskal Methods of treating depression and other related diseases
WO2012149389A2 (en) * 2011-04-27 2012-11-01 Northwestern University Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
WO2014059326A2 (en) * 2012-10-12 2014-04-17 Northwestern University Methods of identifying compounds for treating depression and other related diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006468A1 (en) * 1993-09-01 1995-03-09 Smithkline Beecham Corporation Method for treating migraine headaches
WO2002040538A2 (en) * 2000-11-17 2002-05-23 Bayer Aktiengesellschaft Regulation of human nmda receptor
BRPI0408131A (pt) * 2003-03-06 2006-03-01 Botulinum Toxin Res Ass Inc tratamento com toxina botulina de dor facial e cefaléia crÈnicas relacionadas com sinusite
NZ590793A (en) * 2008-07-23 2012-07-27 Kyowa Hakko Kirin Co Ltd Therapeutic agent for migraine
US8951968B2 (en) * 2009-10-05 2015-02-10 Northwestern University Methods of treating depression and other related diseases
SG183265A1 (en) * 2010-02-11 2012-09-27 Univ Northwestern Secondary structure stabilized nmda receptor modulators and uses thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086828A1 (en) * 2000-08-25 2002-07-04 Harris Robert H. Uses for amino acid anticonvulsants
WO2011003064A2 (en) * 2009-07-02 2011-01-06 Naurex, Inc. Methods of treating neuropathic pain
WO2011044089A2 (en) * 2009-10-05 2011-04-14 Joseph Moskal Methods of treating depression and other related diseases
WO2012149389A2 (en) * 2011-04-27 2012-11-01 Northwestern University Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
WO2014059326A2 (en) * 2012-10-12 2014-04-17 Northwestern University Methods of identifying compounds for treating depression and other related diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2015200322A1 *

Also Published As

Publication number Publication date
JP2020114863A (ja) 2020-07-30
CN106661085A (zh) 2017-05-10
KR20170018072A (ko) 2017-02-15
EP3157943A1 (en) 2017-04-26
RU2017101410A3 (ja) 2019-01-21
BR112016030375A2 (pt) 2017-08-15
WO2015200322A1 (en) 2015-12-30
CA2953170A1 (en) 2015-12-30
AU2015280108A1 (en) 2017-01-19
BR112016030375A8 (pt) 2021-07-13
RU2721401C2 (ru) 2020-05-19
RU2017101410A (ru) 2018-07-24
AU2015280108B2 (en) 2019-11-28
JP6688748B2 (ja) 2020-04-28
JP2017519778A (ja) 2017-07-20
MX2016017388A (es) 2018-02-19

Similar Documents

Publication Publication Date Title
IL285151A (en) Methods for the treatment of fgf21-related disorders
IL279627A (en) A method for treating depression
GB201701673D0 (en) Methods of well treatment
EP3113736A4 (en) Method for treatment of migraine and other headaches
EP3233089A4 (en) Method of treating cancer with cgamp or cgasmp
EP3134436A4 (en) Treatment of h-ras-driven tumors
IL252296A0 (en) Methods for treating multiple sclerosis
EP3234116A4 (en) Methods of treating tissue calcification
EP3193905A4 (en) Methods of treating cervical cancer
EP3226972A4 (en) Methods and compositions for treating migraine and conditions associated with pain
EP3119390A4 (en) Methods of treating cancer
GB201410116D0 (en) Method of treatment
EP3319619A4 (en) Methods of treating colitis
IL253028A0 (en) treatment method
GB201416832D0 (en) Methods of treatment
EP3122349A4 (en) Compositions for the treatment of autodigestion
EP3491129A4 (en) METHODS OF TREATING OSMIDROSIS
EP3134108A4 (en) Agents and methods of treatment
EP3209295A4 (en) Methods of treating ocular conditions
EP3206675A4 (en) METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs
EP3091972A4 (en) Method of treating liver disorders
EP3226864A4 (en) Methods of treating fibrosis
EP3220952A4 (en) Method of treating or preventing stroke
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201512139D0 (en) Methods of treatment

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170105

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20171222

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/06 20060101ALI20171218BHEP

Ipc: A61K 38/07 20060101ALI20171218BHEP

Ipc: C07K 5/103 20060101AFI20171218BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1236971

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210520

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20211201

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1236971

Country of ref document: HK